Pharmacokinetic differences between the enantiomers of lansoprazole and its metabolite, 5-hydroxylansoprazole, in relation to CYP2C19 genotypes
M. Miura, H. Tada, N. Yasui-Furukori, T. Uno, K. Sugawara, T. Tateishi, T. SuzukiVolume:
60
Language:
english
Pages:
6
DOI:
10.1007/s00228-004-0809-1
Date:
November, 2004
File:
PDF, 237 KB
english, 2004